Form 483

Excelsior Medical LLC Form 483, 2010-01-08

FDA issued a Form 483 to Excelsior Medical LLC on 2010-01-08 with 8 public-safe observations.

483· Form 483 issued8 observations

Excelsior Medical LLC · Neptune, United States · Issued January 8, 2010

Overview

  • 8 public-safe observations are available for this inspection.
  • 7 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

8 Jan 2010
21 CFR 803.50(a)(1)

Report of Death or Serious Injury

Cited by Kinh Q Mac

8 Jan 2010
21 CFR 820.30(b)

Establish the design and development plan

Cited by Kinh Q Mac

8 Jan 2010
21 CFR 820.30(g)

Design Validation - Risk analysis not performed/inadequate

Cited by Kinh Q Mac

8 Jan 2010
21 CFR 820.30(g)

Design validation - user needs and intended uses

Cited by Kinh Q Mac

8 Jan 2010
21 CFR 820.50

Purchasing controls, Lack of or inadequate procedures

Cited by Kinh Q Mac

Inspected site

EMExcelsior Medical LLCNeptune, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 820.30(g)Cited across public-safe Form 483 observations2x
21 CFR 803.50(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 820.198(a)(3)Cited across public-safe Form 483 observations1x
21 CFR 820.30(b)Cited across public-safe Form 483 observations1x
21 CFR 820.50Cited across public-safe Form 483 observations1x
21 CFR 820.72(a)Cited across public-safe Form 483 observations1x
21 CFR 820.80(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 8 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere